These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11983264)

  • 1. Engineered Listeria monocytogenes as an AIDS vaccine.
    Lieberman J; Frankel FR
    Vaccine; 2002 May; 20(15):2007-10. PubMed ID: 11983264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of human immunodeficiency virus (HIV)-specific CD8 T-cell responses by Listeria monocytogenes and a hyperattenuated Listeria strain engineered to express HIV antigens.
    Friedman RS; Frankel FR; Xu Z; Lieberman J
    J Virol; 2000 Nov; 74(21):9987-93. PubMed ID: 11024127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Live attenuated Listeria monocytogenes expressing HIV Gag: immunogenicity in rhesus monkeys.
    Jiang S; Rasmussen RA; Nolan KM; Frankel FR; Lieberman J; McClure HM; Williams KM; Babu US; Raybourne RB; Strobert E; Ruprecht RM
    Vaccine; 2007 Oct; 25(42):7470-9. PubMed ID: 17854955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel vaccination protocol with two live mucosal vectors elicits strong cell-mediated immunity in the vagina and protects against vaginal virus challenge.
    Li Z; Zhang M; Zhou C; Zhao X; Iijima N; Frankel FR
    J Immunol; 2008 Feb; 180(4):2504-13. PubMed ID: 18250460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus, and replication-defective adenovirus vectors expressing a human immunodeficiency virus type 1 gag gene.
    Casimiro DR; Chen L; Fu TM; Evans RK; Caulfield MJ; Davies ME; Tang A; Chen M; Huang L; Harris V; Freed DC; Wilson KA; Dubey S; Zhu DM; Nawrocki D; Mach H; Troutman R; Isopi L; Williams D; Hurni W; Xu Z; Smith JG; Wang S; Liu X; Guan L; Long R; Trigona W; Heidecker GJ; Perry HC; Persaud N; Toner TJ; Su Q; Liang X; Youil R; Chastain M; Bett AJ; Volkin DB; Emini EA; Shiver JW
    J Virol; 2003 Jun; 77(11):6305-13. PubMed ID: 12743287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic immunity and mucosal immunity are induced against human immunodeficiency virus Gag protein in mice by a new hyperattenuated strain of Listeria monocytogenes.
    Rayevskaya MV; Frankel FR
    J Virol; 2001 Mar; 75(6):2786-91. PubMed ID: 11222702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors immortalized by HPV-16.
    Gunn GR; Zubair A; Peters C; Pan ZK; Wu TC; Paterson Y
    J Immunol; 2001 Dec; 167(11):6471-9. PubMed ID: 11714814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The induction of HIV Gag-specific CD8+ T cells in the spleen and gut-associated lymphoid tissue by parenteral or mucosal immunization with recombinant Listeria monocytogenes HIV Gag.
    Peters C; Peng X; Douven D; Pan ZK; Paterson Y
    J Immunol; 2003 May; 170(10):5176-87. PubMed ID: 12734365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity in neonatal mice of a hyperattenuated Listeria vaccine directed against human immunodeficiency virus.
    Rayevskaya M; Kushnir N; Frankel FR
    J Virol; 2002 Jan; 76(2):918-22. PubMed ID: 11752181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaginal protection and immunity after oral immunization of mice with a novel vaccine strain of Listeria monocytogenes expressing human immunodeficiency virus type 1 gag.
    Zhao X; Zhang M; Li Z; Frankel FR
    J Virol; 2006 Sep; 80(18):8880-90. PubMed ID: 16940500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a recombinant Listeria monocytogenes expressing an HIV protein that protects mice against viral challenge.
    Mata M; Yao ZJ; Zubair A; Syres K; Paterson Y
    Vaccine; 2001 Jan; 19(11-12):1435-45. PubMed ID: 11163666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuated poxviruses expressing a synthetic HIV protein stimulate HLA-A2-restricted cytotoxic T-cell responses.
    Didierlaurent A; Ramirez JC; Gherardi M; Zimmerli SC; Graf M; Orbea HA; Pantaleo G; Wagner R; Esteban M; Kraehenbuhl JP; Sirard JC
    Vaccine; 2004 Sep; 22(25-26):3395-403. PubMed ID: 15308364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal priming of simian immunodeficiency virus-specific cytotoxic T-lymphocyte responses in rhesus macaques by the Salmonella type III secretion antigen delivery system.
    Evans DT; Chen LM; Gillis J; Lin KC; Harty B; Mazzara GP; Donis RO; Mansfield KG; Lifson JD; Desrosiers RC; Galán JE; Johnson RP
    J Virol; 2003 Feb; 77(4):2400-9. PubMed ID: 12551977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of humoral, mucosal, and cellular immune responses following co-immunization of HIV-1 Gag and Env proteins expressed by Newcastle disease virus.
    Khattar SK; Palaniyandi S; Samal S; LaBranche CC; Montefiori DC; Zhu X; Samal SK
    Hum Vaccin Immunother; 2015; 11(2):504-15. PubMed ID: 25695657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prime-boost vaccination using recombinant Mycobacterium bovis BCG and recombinant vaccinia virus DIs harboring HIV-1 CRF01_AE gag in mice: influence of immunization routes.
    Promkhatkaew D; Matsuo K; Pinyosukhee N; Thongdeejaroen W; Leang-Aramgul P; Sawanpanyalert P; Warachit P
    Southeast Asian J Trop Med Public Health; 2009 Mar; 40(2):273-81. PubMed ID: 19323012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
    Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M
    Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-human immunodeficiency virus-gag CD8+ memory T cells generated in vitro from Listeria-immunized mice.
    Rayevskaya M; Kushnir N; Frankel FR
    Immunology; 2003 Jul; 109(3):450-60. PubMed ID: 12807492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B5-deficient vaccinia virus as a vaccine vector for the expression of a foreign antigen in vaccinia immune animals.
    Viner KM; Girgis N; Kwak H; Isaacs SN
    Virology; 2007 May; 361(2):356-63. PubMed ID: 17188733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fine-tuning the safety and immunogenicity of Listeria monocytogenes-based neonatal vaccine platforms.
    Loeffler DI; Smolen K; Aplin L; Cai B; Kollmann TR
    Vaccine; 2009 Feb; 27(6):919-27. PubMed ID: 19059297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of HIV-1 Nef vaccine components: immunogenicity study of Nef mutants lacking myristoylation and dileucine motif in mice.
    Liang X; Fu TM; Xie H; Emini EA; Shiver JW
    Vaccine; 2002 Sep; 20(27-28):3413-21. PubMed ID: 12213412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.